Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud). - Wikidata - wikimedia - TriplyDB

Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).

Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).

http://www.wikidata.org/entity/Q33733253

about

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.Tizanidine does not affect the linear relation of stretch duration to the long latency M2 response of m. flexor carpi radialis.The relation between Ashworth scores and neuromechanical measurements of spasticity following stroke.Alpha-adrenoceptor modulation in central nervous system trauma: pain, spasms, and paralysis--an unlucky triad.Pharmacokinetic characterization of tizanidine nasal spray, a novel intranasal delivery method for the treatment of skeletal muscle spasm.Management of Tizanidine Withdrawal Syndrome: A Case Report.REPAS, a summary rating scale for resistance to passive movement: Item selection, reliability and validity

P2860

Q30250250-4FFA13EB-3681-4D0E-975B-970C14991394 Q33731444-8E6B9AED-6ED7-447C-9CA2-9A5D1B3EFDBC Q36835638-A07C683B-9D10-4518-817C-1399E1EB3385 Q38302539-AEA78FE8-CDBD-420F-90C9-865E519DFCE6 Q46259564-CDEA895B-4FCA-477C-AD76-BE6FECE629D4 Q50238818-F991F514-3915-40E5-8FE6-9DA08204C157 Q57091588-FF529997-0AC1-4931-AD7A-FEBC346FE802

P2860

Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).

http://www.wikidata.org/entity/Q33733253

description

1994 nî lūn-bûn

@nan

1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@ast

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@en

type

label

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@ast

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@en

prefLabel

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@ast

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@en

P1433

Q33733253-DDFB9B9E-FC26-4E7F-8030-C0A66616D03E

P1476

Q33733253-60303A3E-1DEA-4233-A926-A73D31FD5D06

P2093

Q33733253-106E4513-B2BD-48EB-AA47-E3FE16F3D705

Q33733253-20F2FDEB-16E4-47A0-B216-FDF5E4D1308D

Q33733253-61DC101D-E848-4DD8-BC2F-103E0FE089E6

Q33733253-99F64D1D-345A-4EA6-AA6B-1D9C1FE2014E

Q33733253-BA3BD0B1-F627-4723-A086-58F70782431F

Q33733253-CB58AEB1-9ABD-46BA-ADEF-086377FDC925

P2860

Q33733253-119EAC27-17CB-4A78-AA7D-AA138B89C629

Q33733253-235D7DDB-64EE-41EF-B94B-39139108D2A0

Q33733253-4BA50725-5487-437A-9907-B98040F4A508

Q33733253-549F27A8-81FF-488D-950C-E4A8DE59B8D4

Q33733253-6BAD8FF3-7889-4999-B8C5-2701AF3A6830

Q33733253-6E923259-8CEC-46EA-9792-591FFBD1DB56

Q33733253-B45CC8FE-14ED-4299-98CC-182F3FD0572E

Q33733253-B7D3DD93-3967-4007-865E-FB0AA3C742E3

Q33733253-D03EEBA6-501E-4CC2-9ED3-2D8D7C0C85E1

P304

Q33733253-C943B302-4E44-47D6-BAC2-ED6B56767A2C

P31

Q33733253-BE9198E7-DBFE-466E-86AE-2E53F16A395C

P356

Q33733253-596B40E7-8AEC-484D-BA1A-E9CB0EB60E66

P407

Q33733253-956C9D63-D6CE-42AC-A4BF-0BC455D0C246

P433

Q33733253-82C4D337-B457-4051-9915-01B88DE1E3A9

P478

Q33733253-306DC691-0E89-4916-BC70-0EF9FFAB9357

P577

Q33733253-BAC2FDBC-736C-4E82-B1EE-8BEC00F17481

P5875

Q33733253-436222E4-FD81-4D27-A07D-83345A98F170

P698

Q33733253-21F4B27E-3D3A-4018-A741-A45A8238EFBC

P932

Q33733253-4D115C9D-78C0-4E71-B257-080CE1342259

P356

JNNP.57.11.1355

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Correlations between dose, pla ...... tion of tizanidine (Sirdalud).

@en

P2093

Emre M

http://www.w3.org/2001/XMLSchema#string

Leslie GC

http://www.w3.org/2001/XMLSchema#string

Muir C

http://www.w3.org/2001/XMLSchema#string

Part NJ

http://www.w3.org/2001/XMLSchema#string

Pokorny R

http://www.w3.org/2001/XMLSchema#string

Roberts RC

http://www.w3.org/2001/XMLSchema#string

P2860

Does the Wartenberg pendulum test differentiate quantitatively between spasticity and rigidity? A study in elderly stroke and Parkinsonian patients

Spinal interneurone depression by DS103-282.

Selective depression of synaptic transmission of spinal neurones in the cat by a new centrally acting muscle relaxant, 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1, 3-benzothiodazole (DS103-282).

Descriptive data analysis: a concept between confirmatory and exploratory data analysis.

Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.

Treatment of spasticity with tizanidine in multiple sclerosis.

Tizanidine (DS103-282), a centrally acting muscle relaxant, selectively depresses excitation of feline dorsal horn neurones to noxious peripheral stimuli by an action at alpha 2-adrenoceptors.

Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis.

Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury.

P304

1355-1359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.57.11.1355

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

1994-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15234051

http://www.w3.org/2001/XMLSchema#string

P698

7964811

http://www.w3.org/2001/XMLSchema#string

P932

1073186

http://www.w3.org/2001/XMLSchema#string